New combo therapy tested to control spreading prostate cancer
Disease control
Completed
This study tested a combination treatment for men newly diagnosed with prostate cancer that had spread to a few other sites in the body. The goal was to see if adding an immunotherapy drug (pembrolizumab), with or without an immune-boosting injection (SD-101), to standard radiati…
Phase: PHASE2 • Sponsor: David Oh • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC